S. Adimoolam and J. M. Ford, p53 and regulation of DNA damage recognition during nucleotide excision repair, DNA Repair, vol.2, issue.9, pp.947-954, 2003.
DOI : 10.1016/S1568-7864(03)00087-9

K. S. Albain, W. E. Barlow, S. Shak, G. N. Hortobagyi, R. B. Livingston et al., Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial, The Lancet Oncology, vol.11, issue.1, pp.55-65, 2010.
DOI : 10.1016/S1470-2045(09)70314-6

E. Anderson, Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis, Breast Cancer Research, vol.72, issue.5, pp.197-201, 2002.
DOI : 10.1023/A:1014820500738

T. Ando, H. Ishiguro, Y. Kuwabara, M. Kimura, A. Mitsui et al., Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines, Diseases of the Esophagus, vol.20, issue.1, pp.15-20, 2008.
DOI : 10.1007/s00535-005-1733-6

M. Ayers, W. F. Symmans, J. Stec, A. I. Damokosh, E. Clark et al., Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer, Journal of Clinical Oncology, vol.22, issue.12, pp.2284-2293, 2004.
DOI : 10.1200/JCO.2004.05.166

A. S. Baldwin, Control of oncogenesis and cancer therapy resistance by the transcription factor NF-??B, Journal of Clinical Investigation, vol.107, issue.3, pp.241-246, 2001.
DOI : 10.1172/JCI11991

A. Banerjee, Increased levels of tyrosinated ??-, ??III-, and ??IV-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells, Biochemical and Biophysical Research Communications, vol.293, issue.1, pp.598-601, 2002.
DOI : 10.1016/S0006-291X(02)00269-3

B. M. Barakat, Q. E. Wang, C. Han, K. Milum, D. T. Yin et al., Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis, International Journal of Cancer, vol.4, 2009.
DOI : 10.1128/MCB.18.1.240

C. Barckhausen, W. P. Roos, S. C. Naumann, and B. Kaina, Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair, Oncogene, vol.12, issue.15, 1964.
DOI : 10.1016/S0006-2952(99)00372-X

A. Bartoszek, Metabolic activation of adriamycin by NADPH-cytochrome P450 reductase; overview of its biological and biochemical effects, Acta Biochim. Pol, vol.49, pp.323-331, 2002.

M. Benhar, D. Engelberg, and A. Levitzki, ROS, stress-activated kinases and stress signaling in cancer, EMBO reports, vol.3, issue.5, pp.420-425, 2002.
DOI : 10.1093/embo-reports/kvf094

P. Bhat-nakshatri, C. J. Sweeney, and H. Nakshatri, Identification of signal transduction pathways involved in constitutive NF-??B activation in breast cancer cells, Oncogene, vol.21, issue.13, pp.2066-2078, 2002.
DOI : 10.1074/jbc.275.11.8027

H. Bonnefoi, C. , and P. De, Nouveaux facteurs prédictifs de chimiosensibilité dans le cancer du sein, Bulletin Du Cancer, vol.95, pp.943-950, 2008.

J. Borgel, S. Guibert, and M. Weber, Methylated DNA Immunoprecipitation (MeDIP) from Low Amounts of Cells, pp.149-158, 2012.
DOI : 10.1007/978-1-62703-011-3_9

J. M. Brown and L. D. Attardi, The role of apoptosis in cancer development and treatment response, Nature Reviews Cancer, vol.23, issue.Suppl., pp.231-237, 2005.
DOI : 10.1038/sj.onc.1207528

T. A. Buchholz, A. K. Garg, N. Chakravarti, B. B. Aggarwal, F. J. Esteva et al., The Nuclear Transcription Factor ??B/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer, Clinical Cancer Research, vol.11, issue.23, pp.8398-8402, 2005.
DOI : 10.1158/1078-0432.CCR-05-0885

M. Buyse, S. Loi, L. Van-'t-veer, G. Viale, M. Delorenzi et al., Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer, JNCI: Journal of the National Cancer Institute, vol.98, issue.17, pp.1183-1192, 2006.
DOI : 10.1038/ncponc0591

A. U. Buzdar and G. Hortobagyi, Update on endocrine therapy for breast cancer, Clin Cancer Res, vol.4, pp.527-534, 1998.

Q. Cai, L. Fu, Z. Wang, N. Gan, X. Dai et al., -Methylation of Damaged DNA-binding Protein 2 (DDB2) and Its Function in Nucleotide Excision Repair, Journal of Biological Chemistry, vol.18, issue.23, 2014.
DOI : 10.1126/science.1063127

C. Candé, F. Cecconi, P. Dessen, and G. Kroemer, Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?, Journal of Cell Science, vol.115, issue.24, pp.4727-4734, 2002.
DOI : 10.1242/jcs.00210

L. Carey, C. Perou, and C. Livasy, Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study, JAMA, vol.295, issue.21, pp.2492-2502, 2006.
DOI : 10.1001/jama.295.21.2492

H. Chen, H. Huang, Y. Lin, K. Chang, W. Kuo et al., Comparison and Identification of Estrogen-Receptor Related Gene Expression Profiles in Breast Cancer of Different Ethnic Origins, Breast Cancer: Basic and Clinical Research, vol.1, pp.35-49, 2008.
DOI : 10.4137/BCBCR.S626

M. Christmann and B. Kaina, Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation, Nucleic Acids Research, vol.435, issue.1, 2013.
DOI : 10.1016/S0921-8777(99)00022-1

A. Ciucci, P. Gianferretti, R. Piva, T. Guyot, T. J. Snape et al., Induction of Apoptosis in Estrogen Receptor-Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones: Role of the I??B Kinase/Nuclear Factor-??B Pathway, Molecular Pharmacology, vol.70, issue.5, pp.1812-1821, 2006.
DOI : 10.1124/mol.106.025759

R. Colavitti and T. Finkel, Reactive Oxygen Species as Mediators of Cellular Senescence, IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), vol.57, issue.4-5, pp.277-281, 2005.
DOI : 10.1080/15216540500091890

D. Cremoux and P. , Marqueurs pronostiques et prédictifs de réponse aux traitements des cancers du sein, Bulletin Du Cancer, vol.97, pp.1297-1304, 2010.

S. M. Cutts, A. Nudelman, A. Rephaeli, and D. R. Phillips, The Power and Potential of Doxorubicin-DNA Adducts, IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), vol.57, issue.2, pp.73-81, 2005.
DOI : 10.1080/15216540500079093

S. Dan, T. Tsunoda, O. Kitahara, R. Yanagawa, H. Zembutsu et al., An Integrated Database of Chemosensitivity, p.55, 2002.

L. Daubisse-marliac, P. Delafosse, J. B. Boitard, F. Poncet, P. Grosclaude et al., Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries, Annals of Oncology, vol.15, issue.1, pp.329-334, 2011.
DOI : 10.1158/1055-9965.EPI-05-0603

J. M. Davis, P. M. Navolanic, C. R. Weinstein-oppenheimer, L. S. Steelman, W. Hu et al., Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance, Clin. Cancer Res, vol.9, pp.1161-1170, 2003.

M. J. Dechant, J. Fellenberg, C. G. Scheuerpflug, V. Ewerbeck, and K. Debatin, Mutation analysis of the apoptotic ?death-receptors? and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines, International Journal of Cancer, vol.59, issue.5, pp.661-667, 2004.
DOI : 10.4161/cbt.2.3.398

S. K. Dhar, . St, and D. K. Clair, Manganese superoxide dismutase regulation and cancer, Free Radical Biology and Medicine, vol.52, issue.11-12, pp.2209-2222, 2012.
DOI : 10.1016/j.freeradbiomed.2012.03.009

P. Dj, T. , M. , S. , J. et al., Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells, Cell Growth Differ, vol.12, pp.129-135, 2001.

M. J. Duffy, Predictive Markers in Breast and Other Cancers: A Review, Clinical Chemistry, vol.51, issue.3, pp.494-503, 2005.
DOI : 10.1373/clinchem.2004.046227

W. C. Earnshaw, L. M. Martins, and S. H. Kaufmann, Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis, Annual Review of Biochemistry, vol.68, issue.1, pp.383-424, 1999.
DOI : 10.1146/annurev.biochem.68.1.383

M. Ehrich, S. Zoll, S. Sur, and D. Van-den-boom, A new method for accurate assessment of DNA quality after bisulfite treatment, Nucleic Acids Research, vol.268, issue.5, p.29, 2007.
DOI : 10.1006/abio.1998.3067

M. Emi, R. Kim, K. Tanabe, Y. Uchida, and T. Toge, Targeted therapy against Bcl-2-related proteins in breast cancer cells, Breast Cancer Research, vol.711, issue.6, p.940, 2005.
DOI : 10.1200/jco.2004.22.14_suppl.7505

M. Ennen, R. Klotz, N. Touche, S. Pinel, C. Barbieux et al., DDB2: A Novel Regulator of NF-??B and Breast Tumor Invasion, Cancer Research, vol.73, issue.16, 2013.
DOI : 10.1158/0008-5472.CAN-12-3655

J. Eschenbrenner, S. Winsel, S. Hammer, A. Sommer, K. Mittelstaedt et al., Evaluation of Activity and Combination Strategies with the Microtubule-Targeting Drug Sagopilone in Breast Cancer Cell Lines, Frontiers in Oncology, vol.1, p.44, 2011.
DOI : 10.3389/fonc.2011.00044

J. Estaquier, F. Vallette, J. Vayssiere, and B. Mignotte, The Mitochondrial Pathways of Apoptosis, Advances in Mitochondrial Medicine, pp.157-183, 2012.
DOI : 10.1007/978-94-007-2869-1_7

A. Fantozzi, D. C. Gruber, L. Pisarsky, C. Heck, A. Kunita et al., VEGF-Mediated Angiogenesis Links EMT-Induced Cancer Stemness to Tumor Initiation, Cancer Research, vol.74, issue.5, pp.1566-1575, 2014.
DOI : 10.1158/0008-5472.CAN-13-1641

A. T. Ferguson, R. G. Lapidus, S. B. Baylin, D. , and N. E. , Demethylation of the Estrogen Receptor Gene in Estrogen Receptor-negative Breast Cancer Cells Can Reactivate Estrogen Receptor Gene Expression, Cancer Res, vol.55, pp.2279-2283, 1995.

U. Fischer, R. U. Jänicke, and K. Schulze-osthoff, Many cuts to ruin: a comprehensive update of caspase substrates, Cell Death and Differentiation, vol.10, issue.1, pp.76-100, 2003.
DOI : 10.1038/sj.cdd.4401160

S. Fulda, Tumor resistance to apoptosis, International Journal of Cancer, vol.7, issue.3, pp.511-515, 2009.
DOI : 10.1161/01.RES.88.3.282

S. Fulda and K. Debatin, Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy, Oncogene, vol.25, issue.34, pp.4798-4811, 2006.
DOI : 10.1038/sj.onc.1209608

F. Gadal, A. Starzec, C. Bozic, C. Pillot-brochet, S. Malinge et al., Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells, Journal of Molecular Endocrinology, vol.34, issue.1, pp.61-75, 2005.
DOI : 10.1677/jme.1.01631

URL : https://hal.archives-ouvertes.fr/hal-00126095

L. Galluzzi, S. A. Aaronson, J. Abrams, E. S. Alnemri, D. W. Andrews et al., Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes, Cell Death & Differentiation, vol.15, issue.8, pp.1093-1107, 2009.
DOI : 10.4161/auto.5338

URL : https://hal.archives-ouvertes.fr/inserm-00420382

D. Gewirtz, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochemical Pharmacology, vol.57, issue.7, pp.727-741, 1999.
DOI : 10.1016/S0006-2952(98)00307-4

D. A. Gewirtz, The Four Faces of Autophagy: Implications for Cancer Therapy, Cancer Research, vol.74, issue.3, 2014.
DOI : 10.1158/0008-5472.CAN-13-2966

S. Ghavami, M. Hashemi, S. R. Ande, B. Yeganeh, W. Xiao et al., Apoptosis and cancer: mutations within caspase genes, Journal of Medical Genetics, vol.46, issue.8, pp.497-510, 2009.
DOI : 10.1136/jmg.2009.066944

L. Giacinti, P. P. Claudio, M. Lopez, and A. Giordano, Epigenetic Information and Estrogen Receptor Alpha Expression in Breast Cancer, The Oncologist, vol.11, issue.1, pp.1-8, 2006.
DOI : 10.1634/theoncologist.11-1-1

D. E. Handy and J. Loscalzo, Redox Regulation of Mitochondrial Function, Antioxidants & Redox Signaling, vol.16, issue.11, pp.1323-1367, 2012.
DOI : 10.1089/ars.2011.4123

S. Hayes, P. Shiyanov, X. Chen, R. , and P. , DDB, a Putative DNA Repair Protein, Can Function as a Transcriptional Partner of E2F1, Molecular and Cellular Biology, vol.18, issue.1, pp.240-249, 1998.
DOI : 10.1128/MCB.18.1.240

M. Hirakawa, Y. Sato, H. Ohnuma, T. Takayama, T. Sagawa et al., A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker, Cancer Chemotherapy and Pharmacology, vol.23, issue.Suppl 6, pp.789-797, 2013.
DOI : 10.1200/JCO.2005.01.305

R. Horssen, . Van, T. L. Hagen, and A. M. Eggermont, TNF-?? in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility, The Oncologist, vol.11, issue.4, pp.397-408, 2006.
DOI : 10.1634/theoncologist.11-4-397

G. N. Hortobagyi, Treatment of Breast Cancer, New England Journal of Medicine, vol.339, issue.14, pp.974-984, 1998.
DOI : 10.1056/NEJM199810013391407

R. S. Hotchkiss, A. Strasser, J. E. Mcdunn, and P. E. Swanson, Cell Death, New England Journal of Medicine, vol.361, issue.16, pp.1570-1583, 2009.
DOI : 10.1056/NEJMra0901217

Z. Hu, C. Fan, D. S. Oh, J. S. Marron, X. He et al., The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics, vol.7, issue.1, p.96, 2006.
DOI : 10.1186/1471-2164-7-96

L. Hui, Y. Zheng, Y. Yan, J. Bargonetti, and D. A. Foster, Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D, Oncogene, vol.25, issue.55, pp.7305-7310, 2006.
DOI : 10.1016/S0006-291X(03)00229-8

T. Inoki, S. Yamagami, Y. Inoki, T. Tsuru, T. Hamamoto et al., Human DDB2 splicing variants are dominant negative inhibitors of UV-damaged DNA repair, Biochemical and Biophysical Research Communications, vol.314, issue.4, pp.1036-1043, 2004.
DOI : 10.1016/j.bbrc.2004.01.003

M. Ishikawa, T. Miyauchi, and Y. Kashiwagi, Clinical implications of thymidylate synthetase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activity levels in colorectal carcinoma following radical resection and administration of adjuvant 5-FU chemotherapy, BMC Cancer, vol.24, issue.1, p.188, 2008.
DOI : 10.1159/000098110

T. Itoh, A. Nichols, L. , and S. , Abnormal regulation of DDB2 gene expression in xeroderma pigmentosum group E strains, Oncogene, vol.20, issue.48, pp.7041-7050, 2001.
DOI : 10.1038/sj.onc.1201037

T. Itoh, C. O-'shea, L. , and S. , Impaired Regulation of Tumor Suppressor p53 Caused by Mutations in the Xeroderma Pigmentosum DDB2 Gene: Mutual Regulatory Interactions between p48DDB2 and p53, Molecular and Cellular Biology, vol.23, issue.21, pp.7540-7553, 2003.
DOI : 10.1128/MCB.23.21.7540-7553.2003

T. Itoh, S. Iwashita, M. B. Cohen, D. K. Meyerholz, L. et al., Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis, Human Molecular Genetics, vol.27, issue.13, pp.1578-1586, 2007.
DOI : 10.1093/carcin/bgi350

T. A. Järvinen, M. Tanner, V. Rantanen, M. Bärlund, Å. Borg et al., Amplification and Deletion of Topoisomerase II? Associate with ErbB, 2000.

J. Jassem, T. Pie?kowski, A. P?uza?ska, S. Jelic, V. Gorbunova et al., Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial, Journal of Clinical Oncology, vol.19, issue.6, pp.1707-1715, 2001.
DOI : 10.1200/JCO.2001.19.6.1707

S. Jennifer and S. T. Carew, Modulating autophagy for therapeutic benefit, Autophagy, vol.3, pp.464-467, 2007.

M. G. Kapetanaki, J. Guerrero-santoro, D. C. Bisi, C. L. Hsieh, V. Rapic-otrin et al., The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites, Proceedings of the National Academy of Sciences, vol.117, issue.5, pp.2588-2593, 2006.
DOI : 10.1046/j.0022-202x.2001.01540.x

Z. Kattan, S. Marchal, E. Brunner, C. Ramacci, A. Leroux et al., Damaged DNA Binding Protein 2 Plays a Role in Breast Cancer Cell Growth, PLoS ONE, vol.48, issue.4, 2002.
DOI : 10.1371/journal.pone.0002002.s003

URL : https://hal.archives-ouvertes.fr/hal-00276571

Z. Kattan, V. Minig, P. Leroy, M. Dauca, and P. Becuwe, Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells, Breast Cancer Research and Treatment, vol.8, issue.2, pp.203-215, 2008.
DOI : 10.1128/MCB.17.7.3629

S. H. Kaufmann and W. C. Earnshaw, Induction of Apoptosis by Cancer Chemotherapy, Experimental Cell Research, vol.256, issue.1, pp.42-49, 2000.
DOI : 10.1006/excr.2000.4838

M. Kim, D. Kim, W. Jung, K. , and J. , Expression of metabolismrelated proteins in triple-negative breast cancer, Int J Clin Exp Pathol, vol.7, pp.301-312, 2013.

V. L. Kinnula, C. , and J. D. , Superoxide dismutases in malignant cells and human tumors, Free Radical Biology and Medicine, vol.36, issue.6, pp.718-744, 2004.
DOI : 10.1016/j.freeradbiomed.2003.12.010

A. S. Knoop, H. Knudsen, E. Balslev, B. B. Rasmussen, J. Overgaard et al., Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group, Journal of Clinical Oncology, vol.23, issue.30, 2005.
DOI : 10.1200/JCO.2005.11.007

C. M. Koch, R. M. Andrews, P. Flicek, S. C. Dillon, U. Karaoz et al., The landscape of histone modifications across 1% of the human genome in five human cell lines, Genome Research, vol.17, issue.6, pp.691-707, 2007.
DOI : 10.1101/gr.5704207

G. Kroemer, Mitochondria in cancer, Oncogene, vol.25, issue.34, pp.4630-4632, 2006.
DOI : 10.1038/sj.onc.1209589

G. Kroemer, L. Galluzzi, and C. Brenner, Mitochondrial Membrane Permeabilization in Cell Death, Physiological Reviews, vol.87, issue.1, pp.99-163, 2007.
DOI : 10.1074/jbc.274.17.11549

URL : https://hal.archives-ouvertes.fr/hal-00172652

A. P. Kumar, S. Y. Loo, S. W. Shin, T. Z. Tan, C. B. Eng et al., Manganese Superoxide Dismutase Is a Promising Target for Enhancing Chemosensitivity of Basal-Like Breast Carcinoma, Antioxidants & Redox Signaling, vol.20, issue.15, pp.2326-2346, 2014.
DOI : 10.1089/ars.2013.5295

A. V. Kuznetsov, R. Margreiter, A. Amberger, V. Saks, and M. Grimm, Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death, BBA) - Molecular Cell Research 1813, pp.1144-1152, 2011.
DOI : 10.1016/j.bbamcr.2011.03.002

URL : https://hal.archives-ouvertes.fr/inserm-00633082

U. K. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970.
DOI : 10.1101/SQB.1963.028.01.053

H. C. Lee, W. , and Y. H. , Mitochondrial DNA Instability and Metabolic Shift in Human Cancers, International Journal of Molecular Sciences, vol.104, issue.2, pp.674-701, 2009.
DOI : 10.1073/pnas.0700690104

A. R. Lehmann, D. Mcgibbon, and M. Stefanini, Xeroderma pigmentosum, Orphanet Journal of Rare Diseases, vol.6, issue.1, 2011.
DOI : 10.1073/pnas.022473899

URL : https://hal.archives-ouvertes.fr/inserm-00436508

D. Leroith, R. Jr, and C. T. , The insulin-like growth factor system and cancer, Cancer Letters, vol.195, issue.2, pp.127-137, 2003.
DOI : 10.1016/S0304-3835(03)00159-9

F. Li and G. Sethi, Targeting transcription factor NF-??B to overcome chemoresistance and radioresistance in cancer therapy, BBA) -Reviews on Cancer 1805, pp.167-180, 2010.
DOI : 10.1016/j.bbcan.2010.01.002

X. Li, X. Kong, X. Kong, Y. Wang, S. Yan et al., 53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil, PLoS ONE, vol.86, issue.9, p.74928, 2013.
DOI : 10.1371/journal.pone.0074928.t002

L. Y. Lim, N. Vidnovic, L. W. Ellisen, and C. Leong, Mutant p53 mediates survival of breast cancer cells, British Journal of Cancer, vol.60, issue.9, pp.1606-1612, 2009.
DOI : 10.1038/sj.onc.1206724

J. Liu, M. Lin, C. Zhang, D. Wang, Z. Feng et al., TAp63?? enhances nucleotide excision repair through transcriptional regulation of DNA repair genes, DNA Repair, vol.11, issue.2, pp.167-176, 2012.
DOI : 10.1016/j.dnarep.2011.10.016

G. Van-loo, P. Schotte, M. Van-gurp, H. Demol, B. Hoorelbeke et al., Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation, Cell Death & Differentiation, vol.251, issue.12, pp.1136-1142, 2001.
DOI : 10.1006/bbrc.1998.9425

J. Löwe, H. Li, K. H. Downing, and E. Nogales, Refined structure of ????-tubulin at 3.5 ?? resolution 1 1Edited by I. A. Wilson, Journal of Molecular Biology, vol.313, issue.5, pp.1045-1057, 2001.
DOI : 10.1006/jmbi.2001.5077

M. S. Luijsterburg, M. Lindh, K. Acs, M. G. Vrouwe, A. Pines et al., DDB2 promotes chromatin decondensation at UV-induced DNA damage, The Journal of Cell Biology, vol.60, issue.2, pp.267-281, 2012.
DOI : 10.1128/MCB.00695-06

URL : http://jcb.rupress.org/content/jcb/197/2/267.full.pdf

E. Martinez, V. B. Palhan, A. Tjernberg, E. S. Lymar, A. M. Gamper et al., Human STAGA Complex Is a Chromatin-Acetylating Transcription Coactivator That Interacts with Pre-mRNA Splicing and DNA Damage-Binding Factors In Vivo, Molecular and Cellular Biology, vol.21, issue.20, pp.6782-6795, 2001.
DOI : 10.1128/MCB.21.20.6782-6795.2001

K. Mcpherson, C. M. Steel, and J. M. Dixon, ABC of breast diseases: Breast cancer---epidemiology, risk factors, and genetics, BMJ, vol.321, issue.7261, pp.624-628, 2000.
DOI : 10.1136/bmj.321.7261.624

E. Mechetner, A. Kyshtoobayeva, S. Zonis, H. Kim, R. Stroup et al., Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin, Clin. Cancer Res, vol.4, pp.389-398, 1998.

B. D. Melanson, M. A. Cabrita, R. Bose, J. D. Hamill, E. Pan et al., A novel cis -acting element from the 3???UTR of DNA damage-binding protein 2 mRNA links transcriptional and post-transcriptional regulation of gene expression, Nucleic Acids Research, vol.1829, issue.11, pp.5692-5703, 2013.
DOI : 10.1016/j.bbagrm.2012.08.004

C. Mestre-escorihuela, F. Rubio-moscardo, J. A. Richter, R. Siebert, J. Climent et al., Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas, Blood, vol.109, issue.1, pp.271-280, 2007.
DOI : 10.1182/blood-2006-06-026500

M. Michaud and I. M. , Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice, Science, vol.16, issue.7, pp.1573-1577, 2011.
DOI : 10.1038/cdd.2009.46

V. Minig, Z. Kattan, J. Van-beeumen, E. Brunner, and P. Becuwe, Gene Expression in Human Breast Cancer Cells, Journal of Biological Chemistry, vol.10, issue.21, pp.14165-14176, 2009.
DOI : 10.1002/(SICI)1098-2744(199911)26:3<180::AID-MC7>3.0.CO;2-4

F. Mohn, M. Weber, D. Schübeler, R. , and T. , Methylated DNA Immunoprecipitation (MeDIP), pp.55-64, 2009.
DOI : 10.1007/978-1-59745-522-0_5

D. Molnar-stanciu, V. Guimas, A. Bensalem, and A. Thiery-vuillemin, Th??rapie cibl??e et cancer du sein??: ??tat de l???art, Pathologie Biologie, vol.60, issue.4, pp.254-263, 2012.
DOI : 10.1016/j.patbio.2012.05.012

A. Nag, T. Bondar, S. Shiv, R. , and P. , The Xeroderma Pigmentosum Group E Gene Product DDB2 Is a Specific Target of Cullin 4A in Mammalian Cells, Molecular and Cellular Biology, vol.21, issue.20, pp.6738-6747, 2001.
DOI : 10.1128/MCB.21.20.6738-6747.2001

S. Nakayama, Y. Torikoshi, T. Takahashi, T. Yoshida, T. Sudo et al., Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells, Breast Cancer Research, vol.23, issue.5 Suppl 16, p.12, 2009.
DOI : 10.1016/j.orthres.2005.01.018

A. F. Nichols, T. Itoh, F. Zolezzi, S. Hutsell, L. et al., Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements, Nucleic Acids Research, vol.31, issue.2, pp.562-569, 2003.
DOI : 10.1093/nar/gkg152

A. Notte, L. Leclere, and C. Michiels, Autophagy as a mediator of chemotherapy-induced cell death in cancer, Biochemical Pharmacology, vol.82, issue.5, pp.427-434, 2011.
DOI : 10.1016/j.bcp.2011.06.015

URL : https://hal.archives-ouvertes.fr/hal-00721647

L. W. Oberley, Mechanism of the tumor suppressive effect of MnSOD overexpression, Biomedicine & Pharmacotherapy, vol.59, issue.4, pp.143-148, 2005.
DOI : 10.1016/j.biopha.2005.03.006

K. Oh, S. Emmert, D. Tamura, J. J. Digiovanna, and K. H. Kraemer, Multiple Skin Cancers in Adults with Mutations in the XP-E (DDB2) DNA Repair Gene, Journal of Investigative Dermatology, vol.131, issue.3, pp.785-788, 2011.
DOI : 10.1038/jid.2010.352

G. A. Orr, P. Verdier-pinard, H. Mcdaid, and S. B. Horwitz, Mechanisms of Taxol resistance related to microtubules, Oncogene, vol.22, issue.47, pp.7280-7295, 2003.
DOI : 10.1038/sj.onc.1201658

V. R. Otrin, M. Mclenigan, M. Takao, A. S. Levine, and M. Protic, Translocation of a UV-damaged DNA binding protein into a tight association with chromatin after treatment of mammalian cells with UV light, J Cell Sci, vol.110, pp.1159-1168, 1997.

N. Ozoren and W. S. Deiry, Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAIL, Neoplasia, vol.4, issue.6, pp.551-557, 2002.
DOI : 10.1038/sj.neo.7900270

C. M. Perou, T. Sørlie, M. B. Eisen, M. Van-de-rijn, S. S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.278, issue.6797, pp.747-752, 2000.
DOI : 10.1038/35000501

G. Petrosillo, F. M. Ruggiero, and G. Paradies, from mitochondria, The FASEB Journal, vol.17, issue.15, pp.2202-2208, 2003.
DOI : 10.1016/S0959-440X(03)00008-3

I. O. Petruseva, A. N. Evdokimov, and O. I. Lavrik, Molecular Mechanism of Global Genome Nucleotide Excision Repair, Acta Naturae, vol.6, pp.23-34, 2014.

M. W. Pfaffl, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Research, vol.29, issue.9, p.45, 2001.
DOI : 10.1093/nar/29.9.e45

G. D. Phillips, G. Li, D. L. Dugger, L. M. Crocker, K. L. Parsons et al., Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate, Cancer Research, vol.68, issue.22, pp.9280-9290, 2008.
DOI : 10.1158/0008-5472.CAN-08-1776

N. Platet, A. M. Cathiard, M. Gleizes, and M. Garcia, Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion, Critical Reviews in Oncology/Hematology, vol.51, issue.1, pp.55-67, 2004.
DOI : 10.1016/j.critrevonc.2004.02.001

URL : https://hal.archives-ouvertes.fr/inserm-00144757

E. D. Pleasance, R. K. Cheetham, P. J. Stephens, D. J. Mcbride, S. J. Humphray et al., A comprehensive catalogue of somatic mutations from a human cancer genome, Nature, vol.19, issue.7278, pp.191-196, 2010.
DOI : 10.1016/j.mrfmmm.2004.11.013

E. D. Pleasance, P. J. Stephens, S. O-'meara, D. J. Mcbride, A. Meynert et al., A small-cell lung cancer genome with complex signatures of tobacco exposure, Nature, vol.34, issue.7278, pp.184-190, 2010.
DOI : 10.1016/S0093-7754(01)90072-7

A. Prat, J. S. Parker, O. Karginova, C. Fan, C. Livasy et al., Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, Breast Cancer Research, vol.15, issue.1, p.68, 2010.
DOI : 10.1038/nm0809-842

K. I. Pritchard, H. Messersmith, L. Elavathil, M. Trudeau, F. O-'malley et al., HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy, Journal of Clinical Oncology, vol.26, issue.5, pp.736-744, 2008.
DOI : 10.1200/JCO.2007.15.4716

M. Puumalainen, D. Lessel, P. Rüthemann, N. Kaczmarek, K. Bachmann et al., Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity, Nature Communications, vol.252, 2014.
DOI : 10.1073/pnas.0511160103

E. S. Radisky, R. , and D. C. , Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer, Journal of Mammary Gland Biology and Neoplasia, vol.99, issue.11, pp.201-212, 2010.
DOI : 10.1148/129.2.299

V. Rapic-otrin, V. Navazza, T. Nardo, E. Botta, M. Mclenigan et al., True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product, Human Molecular Genetics, vol.12, issue.13, pp.1507-1522, 2003.
DOI : 10.1093/hmg/ddg174

P. C. Rath and B. B. Aggarwal, TNF-Induced Signaling in Apoptosis, Journal of Clinical Immunology, vol.19, issue.6, pp.350-364, 1999.
DOI : 10.1023/A:1020546615229

J. T. Reardon and A. Sancar, Recognition and repair of the cyclobutane thymine dimer, a major cause of skin cancers, by the human excision nuclease, Genes & Development, vol.17, issue.20, pp.2539-2551, 2003.
DOI : 10.1101/gad.1131003

S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, Oxidative stress, inflammation, and cancer: How are they linked?, Free Radical Biology and Medicine, vol.49, issue.11, pp.1603-1616, 2010.
DOI : 10.1016/j.freeradbiomed.2010.09.006

R. B. Riggins, A. H. Bouton, M. C. Liu, C. , and R. , Antiestrogens, Aromatase Inhibitors, and Apoptosis in Breast Cancer, Vitam. Horm, vol.71, pp.201-237, 2005.
DOI : 10.1016/S0083-6729(05)71007-4

. Role, ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair, Proc. Natl. Acad. Sci. U.S.A, vol.110, pp.1658-1663

N. Roy, T. Stoyanova, C. Dominguez-brauer, H. J. Park, S. Bagchi et al., DDB2, an Essential Mediator of Premature Senescence, Molecular and Cellular Biology, vol.30, issue.11, pp.2681-2692, 2010.
DOI : 10.1128/MCB.01480-09

N. Roy, S. Bagchi, R. , and P. , Damaged DNA Binding Protein 2 in Reactive Oxygen Species (ROS) Regulation and Premature Senescence, International Journal of Molecular Sciences, vol.37, issue.9, pp.11012-11026, 2012.
DOI : 10.3892/ijo_00000702

N. Roy, P. V. Bommi, U. G. Bhat, S. Bhattacharjee, I. Elangovan et al., DDB2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer, Cancer Research, vol.73, issue.12, pp.3771-3782, 2013.
DOI : 10.1158/0008-5472.CAN-12-4069

E. Rutgers, M. J. Piccart-gebhart, J. Bogaerts, S. Delaloge, L. V. Veer et al., The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase, European Journal of Cancer, vol.47, issue.18, pp.2742-2749, 2011.
DOI : 10.1016/j.ejca.2011.09.016

E. Sánchez-tilló, A. Lázaro, R. Torrent, M. Cuatrecasas, E. C. Vaquero et al., ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1, Oncogene, vol.6, issue.24, pp.3490-3500, 2010.
DOI : 10.1016/S0092-8674(00)80625-X

M. Scaltriti, F. Rojo, A. Ocaña, J. Anido, M. Guzman et al., Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer, JNCI Journal of the National Cancer Institute, vol.13, issue.4, pp.628-638, 2007.
DOI : 10.1128/MCB.13.4.2247

A. Scrima, R. Konícková, B. K. Czyzewski, Y. Kawasaki, P. D. Jeffrey et al., Structural Basis of UV DNA-Damage Recognition by the DDB1???DDB2 Complex, Cell, vol.135, issue.7, pp.1213-1223, 2008.
DOI : 10.1016/j.cell.2008.10.045

S. Seitz, P. Wassmuth, J. Fischer, A. Nothnagel, B. Jandrig et al., Mutation analysis and mRNA expression of trail-receptors in human breast cancer, International Journal of Cancer, vol.181, issue.20, pp.117-128, 2002.
DOI : 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L

N. Shinoura, N. Yamamoto, Y. Yoshida, T. Fujita, N. Saito et al., Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas, 2000.

A. Singh and J. Settleman, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, vol.104, issue.34, pp.4741-4751, 2010.
DOI : 10.1016/S0002-9440(10)65297-2

T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. S. Marron et al., Repeated observation of breast tumor subtypes in independent gene expression data sets, Proceedings of the National Academy of Sciences, vol.59, issue.14, pp.8418-8423, 2003.
DOI : 10.1016/S0140-6736(02)11087-7

A. Stanculescu, L. A. Bembinster, K. Borgen, A. Bergamaschi, E. Wiley et al., Estrogen Promotes Breast Cancer Cell Survival in an Inhibitor of Apoptosis (IAP)-dependent Manner, Hormones and Cancer, vol.46, issue.1, pp.127-135, 2010.
DOI : 10.1007/s12672-010-0018-6

C. U. Stirnimann, E. Petsalaki, R. B. Russell, and C. W. Müller, WD40 proteins propel cellular networks, Trends in Biochemical Sciences, vol.35, issue.10, pp.565-574, 2010.
DOI : 10.1016/j.tibs.2010.04.003

T. Stoyanova, N. Roy, D. Kopanja, S. Bagchi, R. et al., DDB2 decides cell fate following DNA damage, Proceedings of the National Academy of Sciences, vol.24, issue.7, pp.10690-10695, 2009.
DOI : 10.1128/MCB.24.7.2649-2661.2004

URL : http://www.pnas.org/content/106/26/10690.full.pdf

K. Sugioka, M. Nakano, H. Totsune-nakano, H. Minakami, S. Tero-kubota et al., Mechanism of O???2 generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems, Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol.936, issue.3, pp.377-385, 1988.
DOI : 10.1016/0005-2728(88)90014-X

N. Sun, C. Sun, C. Lin, L. Pai, and C. C. Chao, Damaged DNA-binding protein 2 (DDB2) protects against UV irradiation in human cells and Drosophila, Journal of Biomedical Science, vol.17, issue.1, p.27, 2010.
DOI : 10.1186/1423-0127-17-27

A. Suresh, L. Guedez, J. Moreb, and J. Zucali, Overexpression of manganese superoxide dismutase promotes survival in cell lines after doxorubicin treatment, British Journal of Haematology, vol.54, issue.3, pp.457-463, 2003.
DOI : 10.1007/BF01877425

H. Tagawa, S. Karnan, R. Suzuki, K. Matsuo, X. Zhang et al., Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM, Oncogene, vol.24, issue.8, pp.1348-1358, 2005.
DOI : 10.1111/j.1349-7006.2004.tb02186.x

T. Tamatani, Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells, International Journal of Oncology, vol.41, issue.3, 2012.
DOI : 10.3892/ijo.2012.1544

T. Tan, C. , and G. , p53 Binds and Activates the Xeroderma Pigmentosum DDB2 Gene in Humans but Not Mice, Molecular and Cellular Biology, vol.22, issue.10, pp.3247-3254, 2002.
DOI : 10.1128/MCB.22.10.3247-3254.2002

J. Tang, C. , and G. , Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein, DNA Repair, vol.1, issue.8, pp.601-616, 2002.
DOI : 10.1016/S1568-7864(02)00052-6

M. A. Tapia, I. González-navarrete, A. Dalmases, M. Bosch, V. Rodriguez-fanjul et al., Inhibition of the Canonical IKK/NF&kappa;B Pathway Sensitizes Human Cancer Cells to Doxorubicin, Cell Cycle, vol.6, issue.18, pp.2284-2292, 2007.
DOI : 10.4161/cc.6.18.4721

D. Trachootham, J. Alexandre, and P. Huang, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nature Reviews Drug Discovery, vol.104, issue.7, pp.579-591, 2009.
DOI : 10.4161/cbt.7.12.7067

L. J. Van-'t-veer, H. Dai, M. J. Van-de-vijver, Y. D. He, A. A. Hart et al., Gene expression profiling predicts clinical outcome of breast cancer, Nature, vol.344, issue.6871, pp.530-536, 2002.
DOI : 10.1056/NEJM200102223440801

P. Viatour, M. Bentires-alj, A. Chariot, V. Deregowski, L. De-leval et al., NF-??B2/p100 induces Bcl-2 expression, Leukemia, vol.15, issue.7, pp.1349-1356, 2003.
DOI : 10.1038/sj.onc.1202351

H. Wang, L. Zhai, J. Xu, H. Y. Joo, S. Jackson et al., Histone H3 and H4 Ubiquitylation by the CUL4-DDB-ROC1 Ubiquitin Ligase Facilitates Cellular Response to DNA Damage, Molecular Cell, vol.22, issue.3, pp.383-394, 2006.
DOI : 10.1016/j.molcel.2006.03.035

H. Wang, H. Bai, Y. Li, J. Sun, W. et al., Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer, World Journal of Gastroenterology, vol.13, issue.38, pp.5060-5064, 2007.
DOI : 10.3748/wjg.v13.i38.5060

W. Wang, J. Cassidy, V. O-'brien, K. M. Ryan, C. et al., Mechanistic and Predictive Profiling of 5-Fluorouracil Resistance in Human Cancer Cells, Cancer Research, vol.64, issue.22, pp.8167-8176, 2004.
DOI : 10.1158/0008-5472.CAN-04-0970

Y. Wang, J. Shi, K. Chai, X. Ying, and B. P. Zhou, The Role of Snail in EMT and Tumorigenesis, Current Cancer Drug Targets, vol.13, issue.9, pp.963-972, 2013.
DOI : 10.2174/15680096113136660102

O. Warburg, On the Origin of Cancer Cells, Science, vol.123, issue.3191, pp.309-314, 1956.
DOI : 10.1126/science.123.3191.309

Y. Wei, T. Fan, Y. , and M. , Inhibitor of apoptosis proteins and apoptosis, Acta Biochimica et Biophysica Sinica, vol.21, issue.4, pp.278-288, 2008.
DOI : 10.1210/en.139.3.1321

B. Weigelt, H. M. Horlings, B. Kreike, M. M. Hayes, M. Hauptmann et al., Refinement of breast cancer classification by molecular characterization of histological special types, The Journal of Pathology, vol.9, issue.2, pp.141-150, 2008.
DOI : 10.1016/S0140-6736(05)17947-1

H. Wildiers, K. Forceville, R. Paridaens, and H. Joensuu, Taxanes and anthracyclines in early breast cancer: which first? The Lancet Oncology, pp.219-220, 2010.

S. W. Wong, K. H. Tiong, W. Y. Kong, Y. C. Yue, C. H. Chua et al., Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73, Breast Cancer Research and Treatment, vol.591, issue.1???3, pp.301-313, 2011.
DOI : 10.1016/j.ejphar.2008.06.028

C. W. Xiao, X. Yan, Y. Li, S. A. Reddy, and B. K. Tsang, Resistance of Human Ovarian Cancer Cells to Tumor Necrosis Factor ?? Is a Consequence of Nuclear Factor ??B-Mediated Induction of Fas-Associated Death Domain-Like Interleukin-1??-Converting Enzyme-Like Inhibitory Protein, Endocrinology, vol.144, issue.2, pp.623-630, 2003.
DOI : 10.1210/en.2001-211024

Q. Zhao, B. M. Barakat, S. Qin, A. Ray, M. A. El-mahdy et al., The p38 Mitogen-activated Protein Kinase Augments Nucleotide Excision Repair by Mediating DDB2 Degradation and Chromatin Relaxation, Journal of Biological Chemistry, vol.46, issue.47, pp.32553-32561, 2008.
DOI : 10.1073/pnas.96.2.424

R. Zhao, C. Han, E. Eisenhauer, J. Kroger, W. Zhao et al., DNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells, DNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells, pp.370-380, 2014.
DOI : 10.1158/1541-7786.MCR-13-0281

A. Zubair and M. Frieri, Role of Nuclear Factor-??B in Breast and Colorectal Cancer, Current Allergy and Asthma Reports, vol.42, issue.17, pp.44-49, 2013.
DOI : 10.1080/00365520600880856

C. Titre-du-projet and U. Cran, Direction scientifique : Prof Master 2 nd année Titre du projet : Influence de la protéine DDB2 sur la réponse des cellules tumorales mammaires aux agents anticancéreux. Direction scientifique : Prof. Philippe Bécuwe et Dr, Master 1 ère année. Titre du projet : Expression et importance de la sémaphorine 6B, 2009.

B. Becuwe, M. Ennen, R. Klotz, B. Barbieux, and S. Grandemange, Manganese superoxide dismutase in breast cancer: From molecular mechanisms of gene regulation to biological and clinical significance, Free Radical Biology and Medicine, vol.77, 2014.
DOI : 10.1016/j.freeradbiomed.2014.08.026

URL : https://hal.archives-ouvertes.fr/hal-01094585

D. *. Brie, R. *. Klotz, S. Miron, S. Moussaoui, C. Mustin et al., Joint analysis of flow cytometry data and fluorescence spectra as a non-negative array factorization problem, Chemometrics and Intelligent Laboratory Systems, vol.137, pp.21-32, 2014.
DOI : 10.1016/j.chemolab.2014.06.003

URL : https://hal.archives-ouvertes.fr/hal-00990043

M. Ennen, R. Klotz, N. Touche, S. Pinel, C. Barbieux et al., DDB2: A Novel Regulator of NF-??B and Breast Tumor Invasion, Cancer Research, vol.73, issue.16, pp.5040-52, 2013.
DOI : 10.1158/0008-5472.CAN-12-3655

R. Klotz, C. Barbieux, V. Besancenot, E. Brunner, S. Pinel et al., Grandemange, S. DDB2 enhances the sensitivity of human breast cancer to chemotherapy by regulating its target genes expression Ecriture en cours

R. Klotz, V. Besancenot, E. Brunner, P. Bécuwe, and S. Grandemange, DDB2: a new regulator of metabolism in breast cancer cells

R. Klotz, V. Besancenot, E. Brunner, P. Bécuwe, and S. Grandemange, La protéine DDB2: un nouveau régulateur de la chimiosensibilité dans les cancers du sein, Journée Recherche « Cancérologie en Lorraine

R. Klotz, V. Besancenot, E. Brunner, P. Bécuwe, and S. Grandemange, DDB2 a new regulator of mitochondrial metabolism and sensitivity to cell death in human breast tumor cells, pp.27-28, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00747857

R. Klotz, V. Besancenot, E. Brunner, P. Bécuwe, and S. Grandemange, DDB2: a new regulator of metabolism and cell death in human breast cancer cells. CTRC-AACR San Antonio Breast Cancer Symposium Poster selected and abstract published in Cancer, p.24, 2012.

R. Klotz, M. Ennen, V. Besancenot, E. Brunner, N. Touche et al., DDB2 a new regulator of metabolism and cell death in human breast tumor cells, Journée Biomédicale, vol.2, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00747606

R. Klotz, V. Besancenot, E. Brunner, P. Bécuwe, and S. Grandemange, DDB2 a new regulator of mitochondrial metabolism and sensitivity to cell death in human breast tumor cells, ONCOTRANS Congress, vol.8, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00747857